Trial
NCT02047214
Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy
Phase IITERMINATEDSAFETYConfidence: HIGH
Sponsor
Cortice Biosciences, Inc.
Collaborators
—
Condition
Glioblastoma Multiforme
Intervention
TPI 287
Why stopped
Due to lack of clinical benefit in the 17 subjects enrolled in the trial to date
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-31